Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Smith & Nephew Snats ( (SNN) ) has provided an announcement.
Smith & Nephew plc, a global medical technology company, announced that an interim dividend of 15.0 US cents per ordinary share will be paid on November 7, 2025. Shareholders in the UK or those who opted for sterling dividends will receive 11.26 pence per share. This announcement, initially made on August 5, 2025, reflects the company’s ongoing commitment to returning value to its shareholders.
The most recent analyst rating on (SNN) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.
Spark’s Take on SNN Stock
According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.
Smith & Nephew Snats’ strong financial performance and positive earnings call outlook are the primary drivers of its stock score. While technical indicators show mixed momentum, and valuation suggests the stock may be expensive, the company’s robust cash flow and strategic initiatives support a positive outlook. Challenges in emerging markets and potential tariff impacts are notable risks.
To see Spark’s full report on SNN stock, click here.
More about Smith & Nephew Snats
Average Trading Volume: 757,059
Technical Sentiment Signal: Buy
Current Market Cap: $15.38B
See more data about SNN stock on TipRanks’ Stock Analysis page.